股息配發率   玩股撇步(動畫小學堂)

  • 現金殖利率: N/A、總殖利率: 0、5年平均現金配發率: N/A
  • 要留意資產負債表的未分配盈餘和配息能力, 如果為負值, 可能會無法發放股利
  • 股利有2個稅要支出, 分別是綜合所得稅和健保補充保費(單筆股利達2萬元以上, 課2.11%)
EPS YoY現金股利 YoY股票股利 YoY現金配發率 YoY股票配發率 YoY全部配發率 YoY
2023 (10)4.4900.0000.0000.0000.0000.000
2022 (9)-3.7700.0000.0000.0000.0000.000
2021 (8)-1.3000.0000.0000.0000.0000.000
2020 (7)-1.8700.0000.0000.0000.0000.000
2019 (6)-3.5800.0000.0000.0000.0000.000
2018 (5)-5.5900.0000.0000.0000.0000.000
2017 (4)-2.9300.0000.0000.0000.0000.000
2016 (3)-3.7100.0000.0000.0000.0000.000
每股盈餘-近20季
EPS QoQ YoY本業EPS QoQ YoY累計EPS QoQ YoY
23Q4 (20)6.541695.12519.23-1.57-157.38-20.774.49315.87219.1
23Q3 (19)-0.4161.32-165.08-0.6141.3536.46-2.08-24.5511.11
23Q2 (18)-1.06-73.774.5-1.04-33.33-19.54-1.67-173.7746.82
23Q1 (17)-0.6160.9-48.78-0.7840.048.68-0.6183.82-48.78
22Q4 (16)-1.56-347.62-403.23-1.30-35.42-11.11-3.77-61.11-190.0
22Q3 (15)0.63156.76270.27-0.96-10.3428.89-2.3425.48-127.18
22Q2 (14)-1.11-170.73-362.5-0.8742.76-24.29-3.14-665.85-383.08
22Q1 (13)-0.41-32.262.38-1.52-29.91-20.63-0.4168.462.38
21Q4 (12)-0.3116.2222.5-1.1713.3329.09-1.30-26.2130.48
21Q3 (11)-0.37-54.17-2.78-1.35-92.86-19.47-1.03-58.4631.33
21Q2 (10)-0.2442.8656.36-0.7044.4457.58-0.65-54.7643.97
21Q1 (9)-0.42-5.032.26-1.2623.6411.89-0.4277.5432.26
20Q4 (8)-0.40-11.1172.22-1.65-46.02-5.1-1.87-24.6747.77
20Q3 (7)-0.3634.5550.68-1.1331.5210.32-1.50-29.3129.91
20Q2 (6)-0.5511.29-7.84-1.65-15.38-81.32-1.16-87.117.73
20Q1 (5)-0.6256.9431.11-1.438.9213.33-0.6282.6831.11
19Q4 (4)-1.44-97.260.0-1.57-24.60.0-3.58-67.290.0
19Q3 (3)-0.73-43.140.0-1.26-38.460.0-2.14-51.770.0
19Q2 (2)-0.5143.330.0-0.9144.850.0-1.41-56.670.0
19Q1 (1)-0.900.00.0-1.650.00.0-0.900.00.0
年/月營收月增率(%)去年同期年增率(%)累計營收累計營收年增率(%)近三月累計營收存貨銷售比自結稅前EPS自結稅前累計EPS備註(年增率變動50%需說明原因)
2024/30.327.3827.920.8240.940.82N/A-
2024/20.2942.270.860.550.590.81N/A主係保健食品銷量增加
2024/10.21-32.9728.860.2128.860.72N/A-
2023/120.3151.847.642.817.40.970.78-
2023/110.2-54.99-4.272.513.91.050.72-
2023/100.4516.15199.312.34.691.060.7本公司新增保健食品業務,整體收入較同期上升
2023/90.3975.3654.311.85-9.670.791.33本公司新增保健食品業務,整體收入較同期上升
2023/80.2226.68-2.811.46-18.680.512.07-
2023/70.1861.58-40.541.24-21.00.472.25-
2023/60.11-40.38-64.891.06-16.460.482.25本公司機台出貨量較去年同期減少,收入下降
2023/50.18-4.21-30.030.95-0.890.621.74-
2023/40.19-23.1535.050.779.910.611.77-
2023/30.2543.4316.870.583.60.581.86-
2023/20.177.2411.710.33-4.440.541.99-
2023/10.16-23.2-17.280.16-17.280.581.85-
2022/120.21-1.5776.422.62114.230.572.0本公司新增動物醫療儀器設備及醫療耗材產品,整體收入較同期上升
2022/110.2140.7280.022.41118.30.621.86本公司新增動物醫療儀器設備及醫療耗材產品,整體收入較同期上升
2022/100.15-40.1191.772.2122.890.631.82本公司新增動物醫療儀器設備及醫療耗材產品,整體收入較同期上升
2022/90.2510.44108.912.05125.590.781.46本公司新增動物醫療儀器設備及醫療耗材產品,整體收入較同期上升
2022/80.23-22.5209.851.79128.160.831.36本公司新增動物醫療儀器設備及醫療耗材產品,整體收入較同期上升
2022/70.3-4.58277.551.57119.690.861.31本公司新增動物醫療儀器設備及醫療耗材產品,整體收入較同期上升
2022/60.3118.879.01.27100.260.711.35本公司新增動物醫療儀器設備及醫療耗材產品,整體收入較同期上升
2022/50.2684.89214.680.96108.210.611.57本公司新增動物醫療儀器設備產品,整體收入較同期上升
2022/40.14-33.596.930.784.980.511.89本公司新增動物醫療儀器設備產品,整體收入較同期上升
2022/30.2137.09171.030.5682.210.561.07本公司新增動物醫療儀器設備產品,整體收入較同期上升
2022/20.15-20.5847.610.3551.990.471.28本公司新增動物醫療儀器設備產品,整體收入較同期上升
2022/10.1963.7855.650.1955.650.431.39本公司新增動物醫療儀器設備產品,整體收入較同期上升
2021/120.120.43-19.61.2220.510.321.71-
2021/110.1249.9174.691.127.340.321.7本公司新增之防疫產品銷量穩定,整體收入較同期上升
2021/100.08-34.7523.650.9919.650.271.97-
2021/90.1263.8131.190.9119.310.271.98本公司新增之防疫產品銷量穩定,整體收入較同期上升
2021/80.07-5.56-40.730.7911.050.321.66-
2021/70.08-54.76-25.180.7122.110.331.62-
2021/60.17108.84169.010.6332.410.331.93係受新冠疫情影響,本公司防疫產品銷量增加。
2021/50.0815.7-16.750.4611.280.232.71-
2021/40.07-8.48-32.470.3820.10.252.48-
2021/30.08-25.321.50.3146.630.312.08-
2021/20.1-16.2669.810.2372.780.381.7本期機台出貨量較去年同期增加,收入上升。
2021/10.12-15.475.350.1275.350.322.03本期機台出貨量較去年同期增加,收入上升
2020/120.15243.1681.111.02-44.190.252.87本月機台出貨量較去年同期增加,收入上升
2020/110.04-32.51-58.070.87-50.070.164.59本期機台出貨量較去年同期減少,收入下降
2020/100.0621.97-31.110.82-49.570.243.03-
2020/90.05-58.0-61.920.76-50.680.282.92本期機台出貨量較去年同期減少,收入下降。
2020/80.1219.2-26.50.71-49.580.292.8-
2020/70.162.65-60.00.58-52.750.273.06本期機台出貨量較去年同期減少,收入下降。
2020/60.06-35.37-57.720.48-50.80.273.12本期機台出貨量較去年同期減少,收入下降。
2020/50.1-6.13-16.090.42-49.530.282.98-
2020/40.1137.56-32.220.32-55.150.243.44本期機台出貨累計量較去年同期減少,收入下降。
2020/30.0824.91-38.040.21-61.690.215.05本年累計機台出貨量較去年同期減少,收入下降。
2020/20.06-13.52-73.440.13-68.630.214.94本期機台出貨量較去年同期減少,收入下降。
2020/10.07-12.63-62.80.07-62.80.264.15本期機台出貨量較去年同期減少,收入下降。
2019/120.08-20.57-61.531.82-43.760.283.87本期X光機台出貨量較去年同期減少,收入下降。
2019/110.110.88-70.341.74-42.510.333.22本期X光機台出貨量較去年同期減少,收入下降。
2019/100.09-32.58-59.691.63-38.910.42.68本期機台出貨量較去年同期減少,收入下降。
2019/90.14-18.93-44.451.54-36.960.571.95-
2019/80.17-35.12-52.271.4-36.120.581.91本期X光機台出貨量較去年同期減少,收入下降。
2019/70.2671.93-8.431.24-33.010.532.09-
2019/60.1528.26-29.970.97-37.510.433.38-
2019/50.12-24.18-43.70.82-38.730.0N/A-
2019/40.1625.74-15.130.7-37.80.0N/A-

股利相關資訊

免責聲明

本網站所有資料僅供參考,如使用者依本資料交易發生交易損失需自行負責,本網站對資料內容錯誤﹑更新延誤不負任何責任。